Active Ingredient(s):Rilpivirine FDA Approved: * May 20, 2011 Pharm Company: *TIBOTEC Category:HIV / AIDS
Rilpivirine, sold under the brand names Edurant and Rekambys, is a medication, developed by Tibotec, used for the treatment of HIV/AIDS. It is a second-generation non-nucleoside reverse transcriptase inhibitor (NNRTI) with higher potency, longer half-life and reduced side-effect profile compared with older NNRTIs such as efavirenz.
1 Medical uses
1.1 Available forms
2 Contraindications and interactions
* May have multiple approval dates, manufacturers, or labelers.